NCT01928212
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Wenzhou Medical College Wenzhou, Zhejiang, China
Clinical trial condition
Synucleinopathies
Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.
3,496 public trials
645 recruiting studies
Synucleinopathies trial results
NCT00479401
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- 248.524.01018 Boehringer Ingelheim Investigational Site Gilbert, Arizona, United States
- 248.524.01004 Boehringer Ingelheim Investigational Site Sun City, Arizona, United States
- 248.524.01016 Boehringer Ingelheim Investigational Site La Jolla, California, United States
- 248.524.01013 Boehringer Ingelheim Investigational Site Oxnard, California, United States
NCT01076452
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- University of California at Los Angeles Los Angeles, California, United States
- University of California at San Francisco San Francisco, California, United States
- VA Medical Center, San Francisco San Francisco, California, United States
- VA Greater Los Angeles Healthcare System, West LA West Los Angeles, California, United States
NCT00466167
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- 248.525.43005 Boehringer Ingelheim Investigational Site Linz, Austria
- 248.525.42003 Boehringer Ingelheim Investigational Site Pardubice, Czechia
- 248.525.42001 Boehringer Ingelheim Investigational Site Prague, Czechia
- 248.525.42005 Boehringer Ingelheim Investigational Site Rakovník, Czechia
NCT01061567
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Boehringer Ingelheim Investigational Site 1 Bad Ischl, Austria
- Boehringer Ingelheim Investigational Site 2 Bad Radkersburg, Austria
- Boehringer Ingelheim Investigational Site 3 Baden, Austria
- Boehringer Ingelheim Investigational Site 4 Baden, Austria
NCT01794195
- Conditions
- Apathy, Basal Ganglia Diseases, Brain Diseases, +13 more
- Locations
-
- CHU Clermont-Ferrand Clermont-Ferrand, France
NCT02177357
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified
Completed
Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease
NCT02172573
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified
NCT01341431
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- Centre d'Investigation Clinique ICM Paris, France
NCT00297778
- Conditions
- Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +9 more
- Locations
-
- 248.596.43003 Boehringer Ingelheim Investigational Site Graz, Austria
- 248.596.43001 Boehringer Ingelheim Investigational Site Innsbruck, Austria
- 248.596.43005 Boehringer Ingelheim Investigational Site Linz, Austria
- 248.596.43004 Boehringer Ingelheim Investigational Site Sankt Pölten, Austria